Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.

Cardiovascular disease is the world’s top killer, claiming over 20.5 million lives in 2021, according to the World Heart ...

Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...

Major Insurer Joins UnitedHealthcare in Covering Cleerly's AI-QCT/AI-CPA Technology, Expanding Access to 61 Million Americans With more than 16 million covered lives, Cigna joins UnitedHealthcare and ...

Here, five cardiology leaders weigh in on the possibilities of ending cardiovascular disease: Gopi Dandamudi, MD. Executive Medical Director of the Center for Cardiovascular Health at Virginia Mason ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

One person dies of cardiovascular disease (CVD) every 34 seconds in the U.S., making it the nation’s leading cause of death. This chronic condition affects roughly 127.9 million Americans, and from ...

Natural Field has achieved new continuous research breakthroughs in co-loading liposome technology, with remarkable progress particularly in the development of co-loading Coenzyme Q10 (CoQ10) liposome ...

A company is working to examine the hearts and cardiovascular systems of former pro athletes, especially NFL players. FOX31's Kim Posey spoke with the experts who are excited about what they could ...

(AP) - Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots. The health care giant ...